Vivici Launches Animal-Free Dairy Protein in the US Active Nutrition Market

Vivici, an ingredients startup, has launched Vivitein BLG, a precision-fermented dairy protein, in the US active nutrition market. The protein, produced without the use of animals, aims to meet the increasing demand for high-quality protein sources in this sector, which was valued at $28.4 billion globally in 2023. Vivitein BLG is self-affirmed as Generally Recognized as Safe (GRAS) in the US and offers functional benefits such as improved solubility and texture compared to traditional dairy-based proteins.

Vivici's precision fermentation technology significantly reduces resource consumption, using 86% less water and generating 68% fewer carbon emissions compared to conventional dairy protein production. The company has secured initial offtake agreements for Vivitein BLG and plans to introduce Vivitein LF, a lactoferrin ingredient, later this year. Vivitein BLG will be showcased at Expo West 2025, where visitors can sample the product and learn more about its applications. Vivici recently closed a €32.5 million Series A funding round to support international expansion, product development, and long-term manufacturing growth, highlighting the company's commitment to providing a new standard of protein in the active nutrition market.